Injectable Influenza Vaccine
Inactive
Contract Opportunity
Notice ID
SPE2DP22D0002
Contract Line Item Number
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Major Command
TROOP SUPPORT MEDICAL
Office
DLA TROOP SUPPORT
Award Details
- Contract Award Date: Feb 25, 2022
- Contract Award Number: SPE2DP22D0002
- Task/Delivery Order Number:
- Contractor Awarded Unique Entity ID: FRHTPHMZMX47
- Contractor Awarded Name: GLAXOSMITHKLINE LLC
- Contractor Awarded Address: Durham, NC 27709 USA
- Base and All Options Value (Total Contract Value): $33,803,616.00
General Information
- Contract Opportunity Type: Award Notice (Original)
- Original Published Date: Feb 25, 2022 02:16 pm EST
- Inactive Policy: 15 days after contract award date
- Original Inactive Date: Mar 12, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: 6505 - DRUGS AND BIOLOGICALS
- NAICS Code:
- 325412 - Pharmaceutical Preparation Manufacturing
- Place of Performance: USA
Description
On February 25, 2022, CLINS 0002, 0004, & 0005 of solicitation SPE2DP-21-R-0131 were awarded to GSK for the 2022/2023 Injectable Influenza Vaccine Contract (SPE2DP22D0002).
Attachments/Links
Contact Information
Contracting Office Address
- MEDICAL SUPPLY CHAIN PHARM FSA 700 ROBBINS AVENUE
- PHILADELPHIA , PA 19111
- USA
Primary Point of Contact
- John Garbarino
- john.garbarino@dla.mil
- Phone Number 2157373123
Secondary Point of Contact
History
- Mar 12, 2022 11:55 pm ESTAward Notice (Original)
- Aug 17, 2021 11:56 pm EDTSolicitation (Original)